Pfizer Announces Top-Line Results of ABRYSVO® for RSV in ...
WEBAug 12, 2024 · Pfizer currently is the only company with an RSV vaccine to help protect older adults, as well as infants through maternal immunization. ABRYSVO is a bivalent vaccine that was designed to provide protection against RSV …
Making an RSV Vaccine Was Hard. Getting People to Take It Is …
WEB2 days ago · New vaccines could help stem the spread of respiratory syncytial virus, but there are already huge inequities in access and uptake. US Centers for Disease Control data shows Latino people are ...
CDC Updates RSV Vaccination Recommendation for Adults
WEBJun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
Federal Officials Revise Recommendations for R.S.V. Vaccine
WEBJun 26, 2024 · The Food and Drug Administration has approved three R.S.V. vaccines. Two of them, GSK’s Arexvy and Pfizer’s Abrysvo, were approved in May last year and were administered during the fall and...
Weekly RSV Vaccination Dashboard | RSVVaxView | CDC
WEBSep 25, 2024 · The Weekly RSV Vaccination Dashboard is designed to share preliminary weekly in-season RSV vaccination information, including vaccination coverage estimates and intent for vaccination, using a variety of data sources including surveys, healthcare claims databases, electronic medical records, and immunization information systems (IISs).
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
WEBMay 4, 2023 · Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
Pfizer Announces Positive Top-Line Data of Phase 3 Global …
WEBNov 1, 2022 · Vaccine efficacy of 81.8% was observed against severe medically attended lower respiratory tract illness due to RSV in infants from birth through the first 90 days of life with high efficacy of 69.4% demonstrated through the first six months of life.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
WEBMay 3, 2023 · The US Food and Drug Administration approved the first vaccine against respiratory syncytial virus, known as RSV, and vaccines are in the works.
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the …
WEBMay 31, 2023 · Pfizer is currently the only company pursuing regulatory applications for an RSV investigational vaccine candidate for both an indication to help protect older adults, as well as an indication to help protect infants through maternal immunization.
FDA approves RSV vaccine for adults ages 60 and up - NBC News
WEBMay 3, 2023 · The Food and Drug Administration on Wednesday approved the world's first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the...
- Some results have been removed